Hesperidin ameliorates TNF-α-mediated insulin resistance in differentiated 3T3-L1 cells

Natural Product Sciences

Volumn 18, Issue 4, 2012, Pages 254-260

  Chae, Byeong Suk ^a   Shin, Tae Yong ^a  

^a Woosuk University   (South Korea)

Author keywords

Adipocyte; Adiponectin; Hesperidin; IL 6; Insulin resistance; PGE2; PPAR y

Indexed keywords

ADIPONECTIN; HESPERIDIN; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; INSULIN RESISTANCE; PROTEIN EXPRESSION; UPREGULATION;

EID: 84874595414     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ajuwon, K.M. and Spurlock M.E., Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-1225 (2005).
2. Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J., and Uehara, M., Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 46, 87-92(2010).
3. Akiyama, S., Katsumata, S., Suzuki, K., Nakaya, Y., Ishimi, Y., and Uehara, M., Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 73, 2779-2782 (2009).
4. Bastard, J.P., Maachi, M, Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J., and Feve, B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12 (2006).
5. Berg, A.H. and Scherer, P.E., Adipose Tissue, Inflammation, and Cardiovascular Disease. Circulation Research 96, 939-949 (2005).
6. Buechler, C., Wanninger, J., and Neumeier, M., Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 17, 2801-2811 (2011).
7. Dallaire, P., Bellmann, K., Laplante, M., Gelinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M.L., Latour, M.G., Lamontagne, J., Trujillo, M.E., Scherer, P.E., Prentki, M., Deshaies, Y., and Marette, A., Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes 57, 1999-2011 (2008).
8. De Taeye, B.M., Novitskaya, T., McGuinness, O.P., Gleaves, L., Medda, M., Covington, J.W., and Vaughan, D.E., Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293, E713-725 (2007).
9. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., and Bahouth, S.W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282 (2004).
10. Fontana, L., Eagon, J.C., Trujillo, M.E., Scherer, P.E., and Klein, S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabete, 56, 1010-1013 (2007).
11. Garg, A., Garg, S., Zaneveld, L.J., and Singla, A.K., Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res. 15, 655-669 (2001).
12. Han, D.I., Hwang, B.Y, Hwang, S.Y, Park, J.H., Son, K.H., Lee, S.H., Chang, S.Y, Kang, S.J., Ro, J.S., and Lee, K.S., Isolation and quantitative analysis of hesperidin from Aurantii Fructus. Kor. J. Pharmacogn. 32, 93-97 (2001).
13. Henkel, J., Neuschäfer-Rube, F., Pathe-Neuschäfer-Rube, A., and Püschel, G P., Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology 50, 781-790 (2009).
14. Hosch, S.E., Olefsky, J.M., and Kim, J.J., APPLied mechanics: uncovering how adiponectin modulates insulin action. Cell Metab. 4, 5-6 (2006).
15. Hsieh, P.S., Jin, J.S., Chiang, C.F., Chan, P.C., Chen, C.H., and Shih, K.C., COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 17, 1150-1157(2009).
16. Jain, M. and Parmar, H.S., Evaluation of antioxidative and antiinflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm. Res. 60, 483-491 (2011).
17. Jung, U.J., Lee, M.K., Park, Y.B., Kang, M.A., and Choi, M.S., Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell. Biol. 38, 1134-1145(2006).
18. Kim, H.J., Higashimori, T., Park, S.Y., Choi, H., Dong, J., Kim, Y.J., Noh, H.L., Cho, Y.R., Cline, G., Kim, J.H., Bachmann, R.A., and Chen, J., Interleukin-6 and insulin resistance. Vitam. Horm. 80, 613-633 (2009).
19. Klover, P.J., Clementi, A.H., and Mooney, R.A., Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146, 3417-3427 (2005).
20. Klover, P.J., Zimmers, TA., Koniaris, L.G., and Mooney, R.A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789 (2003).
21. Liu, T.T., Shih, K.C., Kao, C.C., Cheng, W.T., and Hsieh, P.S., Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats. Chin. J. Physiol. 52, 65-71 (2009).
22. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., and Matsuzawa, Y., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099 (2001).
23. Matsunaga, T., Shoji, A., Gu, N., Joo, E., Li, S., Adachi, T., Yamazaki, H., Yasuda, K., Kondoh, T., and Tsuda, K., γ-Tocotrienol attenuates TNF- α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol. Med. Report 5, 905-909 (2012).
24. Meshkani, R. and Adeli, K., Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42, 1331-1346 (2009).
25. Perreault, M. and Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138-43 (2001).
26. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286, 327-334 (2001).
27. Ricote, M., and Glass, C. K., PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta. 1771, 926-935 (2007).
28. Ruan, H., and Lodish, H.F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 14, 447-455 (2003).
29. Schultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W., and Laudes, M., Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One 5, e14328-14334 (2010).
30. Senn, J.J., Klover, P.J., Nowak, I.A., and Mooney, R.A., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399 (2002).
31. Senn, J.J., Klover, P.J., Nowak, I.A., Zimmers, T.A., Koniaris, L.G., Furlanetto, R.W., and Mooney, R.A., Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746 (2003).
32. Sharma, A.M. and Staels, B., Review: Peroxisome proliferator-activated receptor gamma and adipose tissue - understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92, 386-395 (2007).
33. Sun, H., Zhang, Y., Gao, P., Li, Q., Sun, Y., Zhang, J., and Xu, C., Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol. Cell. Biochem. 347, 183-189 (2011).
34. Staels, B., PPAR agonists and the metabolic syndrome. Therapie. 62, 319-326 (2007).
35. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P.A., Bogardus, C., and Pratley, R.E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 9, 414-417 (2001).
36. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, Jr A.W., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
37. Xu, H., Barnes, GT., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
38. Yeh, C.C., Kao, S.J., Lin, C.G., Wang, S.D., Liu, C.J., and Kao, S.T., The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80, 1821-1831 (2007).
39. Zhang, D., Sun, M., Samols, D., and Kushner, I., STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271, 9503-9509 (1996).